T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapyElaine M. Sloand, Neal S. Young, J. Joseph Melenhorst et al.|Blood|2010Cited by 80
Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapyKevin R. Kelly, Steffan T. Nawrocki, Claudia M. Espitia et al.|Leukemia|2017Cited by 72
Complete mutational spectrum of the autophagy interactome: a novel class of tumor suppressor genes in myeloid neoplasmsValeria Visconte, Jennifer S. Carew, B Przychodzen et al.|Leukemia|2016Cited by 36
Rational cotargeting of HDAC6 and BET proteins yields synergistic antimyeloma activityJennifer S. Carew, Steffan T. Nawrocki, Claudia M. Espitia et al.|Blood Advances|2019Cited by 26
Comprehensive quantitative proteomic profiling of the pharmacodynamic changes induced by MLN4924 in acute myeloid leukemia cells establishes rationale for its combination with azacitidineValeria Visconte, Jennifer S. Carew, Steffan T. Nawrocki et al.|Leukemia|2015Cited by 26